Fingerprint
Dive into the research topics of 'Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and Toxicities'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and Toxicities
Pavlina Sverak, Meredith E. Adams, Stephen J. Haines, Samuel C. Levine, David Nascene, Katherine Sommer, Kathryn Dusenbery, Tina C. Huang, Christopher Moertel
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations